1. Home
  2. EDSA vs LIQT Comparison

EDSA vs LIQT Comparison

Compare EDSA & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • LIQT
  • Stock Information
  • Founded
  • EDSA 2015
  • LIQT 2004
  • Country
  • EDSA Canada
  • LIQT Denmark
  • Employees
  • EDSA N/A
  • LIQT N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • LIQT Industrial Machinery/Components
  • Sector
  • EDSA Health Care
  • LIQT Technology
  • Exchange
  • EDSA Nasdaq
  • LIQT Nasdaq
  • Market Cap
  • EDSA 13.8M
  • LIQT 16.1M
  • IPO Year
  • EDSA N/A
  • LIQT N/A
  • Fundamental
  • Price
  • EDSA $2.05
  • LIQT $1.70
  • Analyst Decision
  • EDSA Strong Buy
  • LIQT Strong Buy
  • Analyst Count
  • EDSA 2
  • LIQT 2
  • Target Price
  • EDSA $13.00
  • LIQT $4.80
  • AVG Volume (30 Days)
  • EDSA 33.4K
  • LIQT 15.9K
  • Earning Date
  • EDSA 08-08-2025
  • LIQT 08-13-2025
  • Dividend Yield
  • EDSA N/A
  • LIQT N/A
  • EPS Growth
  • EDSA N/A
  • LIQT N/A
  • EPS
  • EDSA N/A
  • LIQT N/A
  • Revenue
  • EDSA N/A
  • LIQT $14,986,815.00
  • Revenue This Year
  • EDSA N/A
  • LIQT $36.89
  • Revenue Next Year
  • EDSA N/A
  • LIQT $16.33
  • P/E Ratio
  • EDSA N/A
  • LIQT N/A
  • Revenue Growth
  • EDSA N/A
  • LIQT N/A
  • 52 Week Low
  • EDSA $1.55
  • LIQT $1.34
  • 52 Week High
  • EDSA $5.59
  • LIQT $3.20
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 52.89
  • LIQT 52.96
  • Support Level
  • EDSA $1.91
  • LIQT $1.58
  • Resistance Level
  • EDSA $2.14
  • LIQT $1.64
  • Average True Range (ATR)
  • EDSA 0.12
  • LIQT 0.09
  • MACD
  • EDSA 0.02
  • LIQT -0.01
  • Stochastic Oscillator
  • EDSA 64.52
  • LIQT 44.83

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.

Share on Social Networks: